An Evaluation of the Weibull and the Logistic Models for Cox's Proportional Hazards Model

Cox's proportional hazards model has been widely used in medical researches to evaluate the relationship between prognostic factors of a disease and the occurrence of outcome event. On a theoretical basis, regression coefficient estimated from Cox's proportional hazards model could be approximated by using the Weibull and the logistic model. Breast cancer cases (n=86) diagnosed at the Seoul National University Hospital were selected to evaluate the possibility of some accelerated models as an approximate model to Cox's proportional hazards model. Age at operation, tumor size and lymph node metastasis were the variables concerned in this study. Parameter estimates of two variables from the Weibull model, which seemed not to violate the proportionality assumption of Cox's model, showed almost identical values to those from Cox's proportional hazards model. However, there was a substantial degree of discrepancy in the parameter estimate of another variable, which showed an apparent unproportionality. This study confirmed that both the Weibull and the logistic models could be used as approximate methods to the estimates from Cox's proportional hazards model. Particularly noteworthy was the fact that the PC-SAS system could be successfully applied to survival analysis when the parameters were going to be estimated using Cox's model

Ecologic correlation Study on Nutrients/Foods Intake and Mortal ity for Female Breast Cancer in Korea

In order to investigate the possible role of dieta-ry factors on the recent increase in mortality for female breast cancer in Korea, an ecologic correlation study between per capita intakes of nutrients and foods and the mortality for female breast cancer during the last 10 years was conducted. In spite of the possibility of an ecologic fallacy, the age-adjusted mortality rates for female breast cancer were positively correlated with protein from animal source, total lipid, total animal foods, animal foods to total intake, fresh fish and shellfish, milk and milk products, and meat and meat products. The rates were inversely associated with energy from cereal, total carbohydrate, vegetable foods to total intake, total vegetable foods, daily intake of cereals and grain products, and starch and starch roots. These results suggest that an increased intake of protein- and fat-rich foods rather than carbohydrate-rich foods or vegetables might be associated with the increase in mortality for breast cancer during the last 10 years in Korea

Young age: an independent risk factor for disease-free survival in women with operable breast cancer

BACKGROUND: The incidence of breast cancer in young women (age < 35) is low. The biology of the disease in this age group is poorly understood, and there are conflicting data regarding the prognosis for these women compared to older patients. METHODS: We retrospectively analyzed 2040 consecutive primary invasive breast cancer patients who underwent surgical procedures at our institution between 1990 and 1999. The younger age group was defined as patients aged <35 years at the time of diagnosis. The clinicopathological characteristics and treatment outcomes were compared between younger and older age groups. RESULTS: A total of 256 (12.5%) patients were aged <35. There was a significantly higher incidence of nuclear grade 3 and medullary histological-type tumors in younger patients compared to older patients. Axillary lymph node status, T stage, histological grade, c-erbB2 expression and estrogen receptor status did not differ significantly between the two age groups. Younger patients had a greater probability of recurrence and death at all time periods. Although there was no significant difference in disease-free survival between the two age groups in lymph node-negative patients, the younger group showed worse prognosis among lymph node-positive patients (p < 0.001). In multivariate analysis, young age remained a significant predictor of recurrence (p = 0.010). CONCLUSION: Young age (<35) is an independent risk factor for relapse in operable breast cancer patients

Clinical features and outcomes of gastric variceal bleeding: retrospective Korean multicenter data

Background/AimsWhile gastric variceal bleeding (GVB) is not as prevalent as esophageal variceal bleeding, it is reportedly more serious, with high failure rates of the initial hemostasis (>30%), and has a worse prognosis than esophageal variceal bleeding. However, there is limited information regarding hemostasis and the prognosis for GVB. The aim of this study was to determine retrospectively the clinical outcomes of GVB in a multicenter study in Korea.MethodsThe data of 1,308 episodes of GVB (males:females=1062:246, age=55.0±11.0 years, mean±SD) were collected from 24 referral hospital centers in South Korea between March 2003 and December 2008. The rates of initial hemostasis failure, rebleeding, and mortality within 5 days and 6 weeks of the index bleed were evaluated.ResultsThe initial hemostasis failed in 6.1% of the patients, and this was associated with the Child-Pugh score [odds ratio (OR)=1.619; P<0.001] and the treatment modality: endoscopic variceal ligation, endoscopic variceal obturation, and balloon-occluded retrograde transvenous obliteration vs. endoscopic sclerotherapy, transjugular intrahepatic portosystemic shunt, and balloon tamponade (OR=0.221, P<0.001). Rebleeding developed in 11.5% of the patients, and was significantly associated with Child-Pugh score (OR=1.159, P<0.001) and treatment modality (OR=0.619, P=0.026). The GVB-associated mortality was 10.3%; mortality in these cases was associated with Child-Pugh score (OR=1.795, P<0.001) and the treatment modality for the initial hemostasis (OR=0.467, P=0.001).ConclusionsThe clinical outcome for GVB was better for the present cohort than in previous reports. Initial hemostasis failure, rebleeding, and mortality due to GVB were universally associated with the severity of liver cirrhosis

Isolation and identification of angiotensin I-converting enzyme inhibitory peptides derived from thermolysin-injected beef

Objective This study identified angiotensin I-converting enzyme (ACE) inhibitory peptides in beef M. longissimus injected with thermolysin (80 ppm) and stored for 3 days at 5°C. Methods Crude peptides (molecular weight <3 kDa) were obtained from the thermolysin hydrolysate and separated into seven fractions. Fraction V showing the highest ACE inhibitory activity was further fractionated, yielding subfractions V-15, V-m1, and V-m2, and selected for superior ACE inhibitory activity. Finally, twelve peptides were identified from the three peak fractions and the ACE inhibitory activity (IC50) of each peptide was evaluated. Results The Leu-Ser-Trp, Phe-Gly-Tyr, and Tyr-Arg-Gln peptides exhibited the strongest ACE inhibitory activity (IC50 values of 0.89, 2.69, and 3.09 mM, respectively) and had higher concentrations (6.63, 10.60, and 29.91 pg/g; p<0.05) relative to the other peptides tested. Conclusion These results suggest that the thermolysin injection process is beneficial to the generation of bioactive peptides with strong ACE inhibitory activity

Bioactivities of peptide fractions derived from proteolytic enzyme-injected Hanwoo longissimus muscle in a model system

In this study, crude peptide fractions from Hanwoo loins were released by injecting with proteolytic enzymes [no enzymes (control); protease type XIII (E1); thermolysin (E2); and combination of E1 and E2 (E3)] and their bioactivities were determined. The peptides derived from E2-injected Hanwoo loin exhibited the highest angiotensin I–converting enzyme (ACE) inhibitory activity and vitamin C equivalents antioxidant capacity among the treatments. The released peptide by treatment of E2 and E3 had similar (P > 0.05) inhibitory activity in HT29 cancer cell viability compared with luteolin as a positive control and non-cytotoxic effect on normal cell (3T3-L1). Therefore, the released peptide fraction from thermolysin (E2)-injected Hanwoo beef might contain potent bioactive peptides with ACE inhibitory and antioxidative activity and inhibition effect on certain cancer cell viability